Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Imipenem”

64 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 64 results

Large-scale testing (Phase 3)Study completedNCT03293485
What this trial is testing

Efficacy and Safety of Imipenem+Cilastatin/Relebactam (MK-7655A) in Japanese Participants With Complicated Intra-abdominal Infection or Complicated Urinary Tract Infection (MK-7655A-017)

Who this might be right for
Complicated Intra-abdominal InfectionComplicated Urinary Tract Infection
Merck Sharp & Dohme LLC 83
Post-approval studies (Phase 4)Study completedNCT00871104
What this trial is testing

Fosfomycin Plus Imipenem for Treatment of Infective Endocarditis

Who this might be right for
Infective Endocarditis
Juan A. Arnaiz 50
Not applicableEnded earlyNCT06929585
What this trial is testing

Genicular Artery Embolization (GAE) vs inTra-articular Corticosteroid Injection for Osteoarthritic Knee Pain.

Who this might be right for
Osteoarthritis (OA) of the Knee
National Taiwan University Hospital 1
Post-approval studies (Phase 4)Study completedNCT02149329
What this trial is testing

Short Versus Extended Antibiotic Treatment With a Carbapenem for High-risk Febrile Neutropenia in Hematology Patients With FUO

Who this might be right for
Febrile NeutropeniaHematological Malignancy
Amsterdam UMC, location VUmc 276
Large-scale testing (Phase 3)Study completedNCT00236834
What this trial is testing

The Safety and Effectiveness of Levofloxacin Compared With Imipenem/Cilastatin in Patients With Pneumonia Acquired During Hospitalization

Who this might be right for
Nosocomial Pneumonia
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 438
Not applicableStudy completedNCT03308214
What this trial is testing

The Analysis of Factors Influencing the Vd of Imipenem in Septic Shock Patients

Who this might be right for
Septic Shock
Southeast University, China 25
Not applicableStudy completedNCT03008746
What this trial is testing

Pulmonary Microbiota in Patients With Chronic Obstructive Pulmonary Disease Colonized With P. Aeruginosa Resistant to Imipenem

Who this might be right for
Chronic Obstructive Pulmonary Disease
CHU de Reims 58
Testing effectiveness (Phase 2)Study completedNCT00515034
What this trial is testing

A Safety and Tolerability Study of Doripenem in Patients With Abdominal Infections or Pneumonia

Who this might be right for
Pneumonia, Ventilator-AssociatedPneumonia, BacterialPneumonia+2 more
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 146
Large-scale testing (Phase 3)Study completedNCT02493764
What this trial is testing

Imipenem/Relebactam/Cilastatin Versus Piperacillin/Tazobactam for Treatment of Participants With Bacterial Pneumonia (MK-7655A-014)

Who this might be right for
Bacterial Pneumonia
Merck Sharp & Dohme LLC 537
Post-approval studies (Phase 4)UnknownNCT01297842
What this trial is testing

Ertapenem Versus Meropenem/Imipenem for ESBL+ Gram-negative Infections

Who this might be right for
Drug Safety
Mahidol University 100
Not applicableLooking for participantsNCT03897582
What this trial is testing

Beta-Lactams Dosing In Pneumonia in ICU in Patients Treated by Continuous Renal Replacement Therapy: the BLIPIC Study

Who this might be right for
Beta-lactamContinuous Renal Replacement TherapyPneumonia+1 more
Centre Hospitalier de Valenciennes 65
Post-approval studies (Phase 4)WithdrawnNCT04785924
What this trial is testing

Imipenem/Cilastatin/Relebactam (IMI/REL) in Treatment of CRE Infections

Who this might be right for
Carbapenem-Resistant Enterobacteriaceae InfectionKPCGram-Negative Bacterial Infections+1 more
Wake Forest University Health Sciences
Early research (Phase 1)Study completedNCT04802863
What this trial is testing

Intrapulmonary Pharmacokinetics of XNW4107, Imipenem and Cilastatin in Healthy Subjects

Who this might be right for
Bacterial Infections
Evopoint Biosciences Inc. 21
Not applicableUnknownNCT05285046
What this trial is testing

Phenotypic Profile and Molecular Mechanism of Resistance in Carbapenemase-producing Enterobacterales and Pseudomonas Aeruginosa Isolates From Brazilian Hospitals: Implications for the Introduction of IMIPENEM-RELEBACTAM

Who this might be right for
Bacterial InfectionsAntibiotic Resistant Infection
D'Or Institute for Research and Education 250
Post-approval studies (Phase 4)Ended earlyNCT02474706
What this trial is testing

Evaluation of the Non-inferiority of Cefoxitin Versus Imipenem/Cilastatin in the Treatment of Urinary Tract Infections Caused by ESBL-producing Escherichia Coli

Who this might be right for
Urinary Tract Infections
Central Hospital, Nancy, France 6
Not applicableUnknownNCT01374256
What this trial is testing

Imipenem and Sulbactam in the Treatment of Imipenem-resistant Acinetobacter Baumannii Bacteremia

Who this might be right for
Acinetobacter Bacteraemia
Taipei Veterans General Hospital, Taiwan 200
Large-scale testing (Phase 3)Study completedNCT00136201
What this trial is testing

Study Comparing Tigecycline and Imipenem/Cilastatin in Chinese Subjects With Complicated Intra-Abdominal Infections

Who this might be right for
Abdominal Abscess
Wyeth is now a wholly owned subsidiary of Pfizer 200
Large-scale testing (Phase 3)Study completedNCT06059846
What this trial is testing

Oral Tebipenem Pivoxil Hydrobromide (TBP-PI-HBr) Compared to Intravenous Imipenem-cilastatin in Participants With Complicated Urinary Tract Infection (cUTI) or Acute Pyelonephritis (AP)

Who this might be right for
Urinary Tract InfectionAcute Pyelonephritis
Spero Therapeutics 1,690
Not applicableStudy completedNCT00443885
What this trial is testing

Resistance Rates and Mechanisms of Resistance to Imipenem and Meropenem at UPMC

Who this might be right for
Gram Negative Organism
University of Pittsburgh 500
Testing effectiveness (Phase 2)Study completedNCT02321800
What this trial is testing

Efficacy and Safety of Intravenous Cefiderocol (S-649266) Versus Imipenem/Cilastatin in Complicated Urinary Tract Infections

Who this might be right for
Urinary Tract Infections
Shionogi 452
Load More Results